Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
26
Number of overlapping holdings
20.2%
% of BMED's 147 holdings also in GDOC
57.8%
% of GDOC's 48 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
BOSTON SCIENTIFIC CORP | 3.5% | 5.9% | 3.5% |
|
INTUITIVE SURGICAL INC | 2.3% | 4.6% | 2.3% |
|
COOPER COS INC/THE | 2.1% | 3.6% | 2.1% |
 |
NOVO NORDISK A/S-B | 2.1% | 5.1% | 2.1% |
|
AMGEN INC | 1.9% | 3.5% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to GDOC
|
AMERISOURCEBERGEN CORP | 3.1% |
|
ABBVIE INC | 2.1% |
|
QIAGEN NV | 1.6% |
|
WATERS CORP | 1.6% |
|
BIO-TECHNE CORPORATION | 1.5% |
|
BLUEPRINT MEDICINES CORP. | 1.5% |
 |
GERRESHEIMER AG | 1.5% |
|
STRYKER CORP | 1.5% |
|
MASIMO CORPORATION | 1.4% |
|
SAREPTA THERAPEUTICS INC | 1.4% |
BMED Underweight Relative to GDOC
|
ELI LILLY & CO | -8.8% |
 |
ASTRAZENECA PLC | -5.2% |
|
NOVO NORDISK A/S-B | -3.0% |
|
ZIMMER HOLDINGS INC | -2.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -2.8% |
 |
CSL LIMITED | -2.8% |
|
BRISTOL-MYERS SQUIBB CO | -2.7% |
|
INSULET CORP | -2.7% |
|
BOSTON SCIENTIFIC CORP | -2.5% |
|
INTUITIVE SURGICAL INC | -2.3% |